Analysis of lupus activity in end-stage renal disease treated by hemodialysis

Internal Medicine

Volumn 40, Issue 7, 2001, Pages 598-602

  Okano, Kazuhiro ^a   Yumura, Wako ^a   Nitta, Kousaku ^a   Uchida, Keiko ^a   Ohnuki, Takako ^a   Kawashima, Akira ^a   Nihei, Hiroshi ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Prognosis; Relapse; Renal failure; Systemic lupus erythematosus

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; CHRONIC KIDNEY FAILURE; FEMALE; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; RENAL DIALYSIS; RETROSPECTIVE STUDIES;

EID: 0035404513     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.40.598     Document Type: Article

References (17)

1. Nossent HC, Swaak TJG, Berden JHM, for the Dutch Working Party on SLE. Systemic lupus erythematosus: analysis of disease activity in 55 patients with end-stage renal failure treated with hemodialysis or continuous ambulatory peritoneal dialysis. Am J Med 89: 169-174, 1990.
2. Rosner S, Ginzler EM, Diamond HS, et al. A multicenter study of outcome in systemic lupus erythematosus. II. Causes of death. Arthritis Rheum 25: 612-617, 1982.
3. Correia P, Cameron JS, Ogg CS, Williams DG, Bewick M, Hicks JA. End-stage renal failure in systemic lupus nephritis. Clin Nephrol 22: 293-302, 1984.
4. Cheigh JS, Kim H, Stenzel KH, et al. Systemic lupus erythematosus in patients with end-stage renal disease: long-term follow-up on the prognosis of patients and the evolution of lupus activity. Am J Kidney Dis 16: 189-195, 1990.
5. Szeto C, Li PK, Wong TY, Leung C, Lui S. Factors associated with active lupus erythematosus after endstage renal disease. J Rheum 25: 1520-1525, 1998.
6. Fries JF, Powers R, Kempson RL. Late stage lupus nephropathy. J Rheum 1: 166-175, 1974.
7. Pahl MV, Vaziri ND, Saiki JK, Upham T, Ness R. Chronic hemodialysis in end-stage lupus nephritis: changes of clinical and serological activities. Int J Artif Organs 8: 423-428, 1984.
8. Jarrett MP, Santhanam S, Del Greco F. The clinical course of end-stage renal disease in systemic lupus erythematosus. Arch Intern Med 143: 1353-1356, 1983.
9. Coplon NS, Diskin CJ, Petersen J, Swenson RS. The long-term clinical course of systemic lupus eryhtematosus in end-stage renal disease. N Eng J Med 308: 186-190, 1983.
10. Rodby RA, Korbet SM, Lewis EJ. Persistent of clinical and serologic activity in patients with systemic lupus erythematosus undergoing peritoneal dialysis. Am J Med 83: 613-618, 1987.
11. Swaak AJ, Nossent JC, Bronsveld W, et al. Systemic lupus erythematosus. II. Observation on the occurrence of exacerbations in the disease course. Dutch experience with 110 patients studied prospectively. Ann Rheum Dis 48: 455-460, 1989.
12. Liang MH, Socher SA, Larson MG, Schur PH. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 32: 1107-1118, 1989.
13. Krane NK, Burjak K, Archie M, O'Donovan R. Persistent lupus activity in end-stage renal disease. Am J Kidney Dis 33: 872-879, 1999.
14. Dooley MA, Hogan S, Jennette C, Falk R, and Glomerular Disease Collaborative Network. Cyclophosphamide therapy for lupus nephritis: poor renal survival in black Americans. Kidney Int 51: 1188-1195, 1997.
15. Ward MM, Studenski S. Clinical manifestations of systemic lupus erythematosus. Arch Intern Med 150: 849-853, 1990.
16. Reveille JD, Bartolucci A, Alarcon GS. Prognosis in systemic lupus erythematosus. Arthritis Rheum 33: 37-48, 1990.
17. Petri M, Perez-Gutthann S, Longenecker JC, Hochberg M. Morbidity of systemic lupus erythematosus: role of race and socioeconomic status. Am J Med 91: 345-353, 1991.